Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERU INC. Director's Dealing 2016

Dec 6, 2016

34598_dirs_2016-12-06_a42a0833-902b-4713-975e-a38a8d7b440a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: FEMALE HEALTH CO (FHCO)
CIK: 0000863894
Period of Report: 2016-10-31

Reporting Person: FISCH HARRY (Director, 10% Owner)
Reporting Person: K&H Fisch Family Partners, LLC (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 54504 Direct
Common Stock 606536 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Class A Preferred Stock - Series 4 $ Common Stock (486640) Direct
Class A Preferred Stock - Series 4 $ Common Stock (6632560) Indirect

Footnotes

F1: Includes 45,112 shares of Common Stock held jointly by Dr. Fisch and his spouse.

F2: The securities are held by K&H Fisch Family Partners, LLC, of which Dr. Fisch is the sole manager. Dr. Fisch disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that Dr. Fisch is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F3: Each share of Class A Preferred Stock - Series 4 will automatically convert into 40 shares of Common Stock of the Issuer upon receipt by the Issuer of approval by the affirmative vote of the holders of the Issuer's capital stock by the required vote under the Wisconsin Business Corporation Law and the NASDAQ listing rules, as applicable, of (i) an amendment to the Issuer's Amended and Restated Articles of Incorporation to increase the total number of authorized shares of Common Stock by a sufficient amount to permit such conversion and (ii) the conversion of the Class A Preferred Stock - Series 4 pursuant to applicable NASDAQ rules.

F4: The Class A Preferred Stock - Series 4 has no expiration date.

F5: Includes 383,960 shares of Common Stock issuable upon the conversion of 9,599 shares of Class A Preferred Stock - Series 4 held jointly by Dr. Fisch and his spouse.